| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.001 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.39 | 0.003 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |